- Home
- IOVA vs RMTI Comparison
IOVA vs RMTI Comparison
Compare IOVA & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IOVA
- RMTI
- Stock Information
- Founded
- IOVA 2007
- RMTI 1994
- Country
- IOVA United States
- RMTI United States
- Employees
- IOVA N/A
- RMTI N/A
- Industry
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- RMTI Biotechnology: Pharmaceutical Preparations
- Sector
- IOVA Health Care
- RMTI Health Care
- Exchange
- IOVA Nasdaq
- RMTI Nasdaq
- Market Cap
- IOVA 975.1M
- RMTI 41.0M
- IPO Year
- IOVA N/A
- RMTI 1998
- Fundamental
- Price
- IOVA $2.31
- RMTI $1.14
- Analyst Decision
- IOVA Buy
- RMTI Strong Buy
- Analyst Count
- IOVA 11
- RMTI 2
- Target Price
- IOVA $11.90
- RMTI $4.00
- AVG Volume (30 Days)
- IOVA 11.5M
- RMTI 572.5K
- Earning Date
- IOVA 11-06-2025
- RMTI 11-12-2025
- Dividend Yield
- IOVA N/A
- RMTI N/A
- EPS Growth
- IOVA N/A
- RMTI N/A
- EPS
- IOVA N/A
- RMTI N/A
- Revenue
- IOVA $241,525,000.00
- RMTI $87,966,000.00
- Revenue This Year
- IOVA $68.14
- RMTI N/A
- Revenue Next Year
- IOVA $56.64
- RMTI $10.99
- P/E Ratio
- IOVA N/A
- RMTI N/A
- Revenue Growth
- IOVA 636.99
- RMTI N/A
- 52 Week Low
- IOVA $1.64
- RMTI $0.78
- 52 Week High
- IOVA $12.51
- RMTI $5.15
- Technical
- Relative Strength Index (RSI)
- IOVA 54.05
- RMTI 42.28
- Support Level
- IOVA $2.10
- RMTI $1.12
- Resistance Level
- IOVA $2.41
- RMTI $1.19
- Average True Range (ATR)
- IOVA 0.12
- RMTI 0.06
- MACD
- IOVA 0.02
- RMTI 0.00
- Stochastic Oscillator
- IOVA 72.97
- RMTI 31.58
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
About RMTI Rockwell Medical Inc.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, and acid and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate among others.